William Forbes
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-01–present
-
Heron Therapeutics, Inc. /De/ (HRTX)
Source not stated
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Development Officer | $609,881 | $1,687,765 |
| 2024 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Development Officer | $592,250 | $1,536,130 |
| 2023 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Development Officer | $329,519 | $1,458,106 |
| 2022 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Development Officer | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.